NCT01690286View on ClinicalTrials.gov

Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

JNJ-38518168 3 mg

One oral daily dose of JNJ-38518168 3 mg for 25 days.

DRUG

JNJ-38518168 30 mg

One oral daily dose of JNJ-38518168 30 mg for 25 days.

DRUG

JNJ-38518168 10 mg

One oral daily dose of JNJ-38518168 10 mg for 25 days.

DRUG

Ketoconazole 200 mg

Oral doses of ketoconazole 200 mg every 12 hours, from Day 22 through Day 25.

Trial Locations (1)

Unknown

Neptune City

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT01690286 - Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers | Biotech Hunter | Biotech Hunter